Sunshine Biopharma Inc. (NASDAQ:SBFM) traded higher on Wednesday, with a session volume of 19.07 million compared to an average volume of 88.16K, according to data from Benzinga Pro. The company on ...

Allele will generate mRNA reprogrammed cGMP iPSC lines; conduct R&D to differentiate iPSC into liver cells including hepatocytes, cholangiocytes, endothelial progenitors, hepatic stellate cells, etc.; ...

Ionizable lipid nanoparticles (LNPs) that deliver nucleic acid therapeutics to the liver have been successful in the clinic, but achieving LNP delivery to other organs has been challenging. Reporting ...

The earliest iteration of LNPs was the development of liposomes in the 1960s, with the first liposome-based drug product, Doxil, receiving FDA approval in 1995. In the early 1990s, a second generation ...

CRISPR gene editing has revolutionized the field of molecular biology, offering precise, efficient, and versatile tools for genome modification. The technology has rapidly evolved beyond the original ...